Status:
COMPLETED
Immune Responses to BCG Vaccination in Malawi and the UK
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Conditions:
Immunity, Cellular
Hypersensitivity, Delayed Type
Eligibility:
All Genders
12-25 years
Phase:
PHASE2
Brief Summary
BCG vaccination has been found to provide greater protection against TB in the UK than in Malawi. This study compares immune responses in BCG-vaccinated and unvaccinated teenagers and young adults in ...
Eligibility Criteria
Inclusion
- BCG unvaccinated
- HIV negative
- Not pregnant
- Informed Consent
Exclusion
- HIV positive
- Pregnant
- Seriously ill
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00241657
Last Update
December 15 2005
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Karonga Prevention Study
Chilumba, Karonga District, Malawi, PO Box 36
2
Redbridge and Waltham Forest Primary Care Trust
Ilford, Essex, United Kingdom, IG1 2QX